COAGULATION FACTOR VIII DEFICIENT PLASMA OTXW17 SMN 10446411

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2017-03-03 for COAGULATION FACTOR VIII DEFICIENT PLASMA OTXW17 SMN 10446411 manufactured by Siemens Healthcare Diagnostics Products Gmbh.

Event Text Entries

[69017056] The customer contacted the siemens customer care center questioning the higher results obtained on the bcs xp relative to other non-siemens systems. Siemens headquarters support center (hsc) representatives have evaluated the information provided. Hsc concluded that review of all available information gives no indication of a systemic issue with the bcs xp system, reagent material, or laboratory practices at the customer laboratory. Routine quality control as well as prior survey samples recover acceptably. An overall problem with the fviii % activity application with actin fsl on the bcs xp system can be excluded. Patient comparisons have been conducted and demonstrate acceptable comparison for fviii % activity between the alternate vendor methods (non-siemens). Recovery of the samples fviii % activity on an alternate instrument system with actin fsl reagent and factor viii deficient plasma also was consistent with the bcs xp system recovery. Additionally, comparison across various lots of actin fsl compare well. Comparison of multiple external quality assessment survey vendor samples do not demonstrate a systemic bias. A clear difference in recovery with this specific sample is demonstrated between the application of siemens fviii with actin fsl on the bcsp xp as compared to competitors systems. The patient had received helixate fs product (recombinant factor viii concentrate) prior to collection of this sample. The recovery with siemens products is believed to be accurate for the sample provided to the laboratory for analysis. A false low bias is believed to be demonstrated with the alternate vendor products. The customer has confirmed that no irreparable harm was caused to the patient based upon the original value reported. The device is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


[69017057] A factor viii (fviii) result on a patient sample was questioned as discordant relative to values obtained with alternate reagent methodologies. The sample was tested with coagulation factor viii deficient plasma using the dade actin fsl reagent on the bcs xp instrument. The same sample was sent to alternate laboratories for testing. Lower results were obtained with two alternate non-siemens methodologies on non-siemens instruments. The physician questioned the initial fviii results with the siemens system as discordant with the clinical presentation. Patient did receive fviii concentrate four hours before the testing for fviii was performed. There is no indication that patient treatment was altered or prescribed on the basis of the questioned as discordant fviii result. There was no report of adverse health consequences as a result of the questioned as discordant fviii result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9610806-2017-00028
MDR Report Key6376100
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2017-03-03
Date of Report2017-03-03
Date of Event2017-02-02
Date Mfgr Received2017-02-02
Device Manufacturer Date2016-06-06
Date Added to Maude2017-03-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJAMES MORGERA
Manufacturer StreetGLASGOW BUSINESS COMMUNITY 500 GBC DRIVE PO BOX 6101
Manufacturer CityNEWARK DE 197146101
Manufacturer CountryUS
Manufacturer Postal197146101
Manufacturer Phone3026318356
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer StreetEMIL VON BEHRING STRASSE 76
Manufacturer CityMARBURG, D-35041
Manufacturer CountryGM
Manufacturer Postal CodeD-35041
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOAGULATION FACTOR VIII DEFICIENT PLASMA
Generic NameCOAGULATION FACTOR VIII DEFICIENT PLASMA
Product CodeGJT
Date Received2017-03-03
Catalog NumberOTXW17 SMN 10446411
Lot Number547633
Device Expiration Date2018-05-18
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer AddressEMIL VON BEHRING STRASSE 76 MARBURG, D-35041 GM D-35041


Patients

Patient NumberTreatmentOutcomeDate
10 2017-03-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.